InvestorsHub Logo
Followers 5
Posts 359
Boards Moderated 0
Alias Born 01/10/2019

Re: Suvorov post# 40118

Thursday, 04/25/2019 9:48:13 AM

Thursday, April 25, 2019 9:48:13 AM

Post# of 232883
Your "arguments" have been debunked a hundred times already so I won't bother to do so once again in detail.

(1) Licensing and partnering interests only came up relatively recently after excellent mono data and the Prostagene acquisition (prognostic test, cancer potential).

(2) It is indeed a very profitable strategy to buy nano-caps when they are depressed without scientific reasons, even if you choose a loser. For instance, I bought 10000 shares of Scynexis at 0.36, and look where it is now. Same goes for CorMedix. Of course, with Achaogen etc. it wouldn't have worked, but in the world of small biotechs you can be wrong 8 out of 10 times if you choose 2 correctly.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News